Takeda Y, Nakabayashi M
J Clin Invest. 1974 Jan;53(1):154-62. doi: 10.1172/JCI107533.
Three kinds of plasmin were found to be generated when plasminogen or [(125)I]plasminogen was incubated at 32 degrees C for longer than 20 min in urokinase and 50% glycerol. Each plasmin was then separated by G-200 or G-75 Sephadex filtration, and its physicochemical properties were determined. The molecular weights of the three plasmins as determined by G-200 Sephadex filtration were 125,000+/-5,000(SD), 63,000+/-2,000(SD), and 31,500+/-1,000(SD), and those by sodium dodecyl sulfate(SDS)-polyacrylamide electrophoresis were 130,000+/-5,000(SD), 64,000+/-3,000(SD), and 32,000+/-1,500(SD). It was also found that during the incubation of the smallest plasmin in SDS and beta-mercaptoethanol it was further split into two smaller pieces of about 16,000 mol wt and that polymer proteins of 95,000+/-2,000(SD) and 48,000+/-1,500(SD) mol wt were formed. Despite these differences in the molecular size of the three plasmins, the specific activity of each plasmin was closely similar and in case of human plasmins averaged 29+/-0.9(SD) CTA units/mg plasmin and in case of canine plasmins 8.5+/-0.54(SD) CTA units/mg plasmin. Then, using human plasmin of the smallest size (mol wt 31,500), the total plasma antiplasmin capacity was determined in 20 normal human plasma, which averaged 7.8+/-2(SD) CTA units of plasmin per milliliter plasma. Studies were next made of the affinity of human [(125)I]-plasmin of the smallest size with albumin, gamma globulin, alpha(2)-macroglobulin, alpha(1)-antitrypsin, fibrinogen, and fibrin. The results were 0%, 0%, 14.6+/-0.5(SD)%, 17.6+/-0.6(SD)%, 21+/-0.5(SD)%, and 20.5+/-0.6(SD)%, respectively, of [(125)I]plasmin available and were unaltered when the amount of [(125)I]plasmin was increased to twice and four times the original amount. Finally, the plasma disappearance half-life of canine [(125)I]plasmin of the smallest size was studied in five healthy dogs, which averaged 14.2+/-0.63(SD) h. These results support the concept that the combination between plasmin and plasmin inhibitors is reversible and indicate that fibrinogen and fibrin have greater affinities than alpha(2)-macroglobulin or alpha(1)-antitrypsin.
当纤溶酶原或[(125)I]纤溶酶原在尿激酶和50%甘油中于32℃孵育超过20分钟时,发现会产生三种纤溶酶。然后通过G - 200或G - 75葡聚糖凝胶过滤分离每种纤溶酶,并测定其理化性质。通过G - 200葡聚糖凝胶过滤测定的三种纤溶酶的分子量分别为125,000±5,000(标准差)、63,000±2,000(标准差)和31,500±1,000(标准差),通过十二烷基硫酸钠(SDS)-聚丙烯酰胺电泳测定的分子量分别为130,000±5,000(标准差)、64,000±3,000(标准差)和32,000±1,500(标准差)。还发现,在最小的纤溶酶于SDS和β-巯基乙醇中孵育期间,它会进一步裂解为两个分子量约为16,000的较小片段,并且形成了分子量为95,000±2,000(标准差)和48,000±1,500(标准差)的聚合物蛋白。尽管这三种纤溶酶的分子大小存在这些差异,但每种纤溶酶的比活性非常相似,人纤溶酶的平均比活性为29±0.9(标准差)CTA单位/毫克纤溶酶,犬纤溶酶的平均比活性为8.5±0.54(标准差)CTA单位/毫克纤溶酶。然后,使用最小尺寸(分子量31,500)的人纤溶酶,测定了20份正常人血浆中的总血浆抗纤溶酶能力,平均每毫升血浆为7.8±2(标准差)CTA单位的纤溶酶。接下来研究了最小尺寸的人[(125)I] - 纤溶酶与白蛋白、γ球蛋白、α(2)-巨球蛋白、α(1)-抗胰蛋白酶、纤维蛋白原和纤维蛋白的亲和力。结果分别为可用[(125)I]纤溶酶的0%、0%、14.6±0.5(标准差)%、17.6±0.6(标准差)%、21±0.5(标准差)%和20.5±0.6(标准差)%,当[(125)I]纤溶酶的量增加到原始量的两倍和四倍时,这些结果未改变。最后,在五只健康犬中研究了最小尺寸的犬[(125)I]纤溶酶在血浆中的消失半衰期,平均为14.2±0.63(标准差)小时。这些结果支持纤溶酶与纤溶酶抑制剂之间的结合是可逆的这一概念,并表明纤维蛋白原和纤维蛋白的亲和力大于α(2)-巨球蛋白或α(1)-抗胰蛋白酶。